Raleigh Capital Management’s Inogen INGN Stock Holding History

Raleigh Capital Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29	Closed	-$204	–	612
2025 Q2	$204	Buy	+29	New	+$195	﹤0.01%	570

Other funds holding INGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Raleigh Capital Management's INGN Position: Q3 2025 in Review

Raleigh Capital Management sold out of Inogen (INGN) in Q3 2025, closing a stake of 29 shares — an estimated $204 sold.

Raleigh Capital Management first reported a position in INGN in Q2 2025 and held it in 1 quarter. The position peaked at $204 in Q2 2025. 131 funds tracked by Wall St. Rank hold INGN as of Q3 2025.

Raleigh Capital Management reported no remaining Inogen position as of Q3 2025 after selling out during the quarter.
Raleigh Capital Management sold 29 Inogen shares in Q3 2025, an estimated $204.
Raleigh Capital Management first reported a position in Inogen in Q2 2025 and held it in 1 quarter.
Raleigh Capital Management's Inogen position peaked at $204 in Q2 2025.
131 funds tracked by Wall St. Rank held Inogen as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.